JP2024524215A5 - - Google Patents

Info

Publication number
JP2024524215A5
JP2024524215A5 JP2023578919A JP2023578919A JP2024524215A5 JP 2024524215 A5 JP2024524215 A5 JP 2024524215A5 JP 2023578919 A JP2023578919 A JP 2023578919A JP 2023578919 A JP2023578919 A JP 2023578919A JP 2024524215 A5 JP2024524215 A5 JP 2024524215A5
Authority
JP
Japan
Prior art keywords
group
protected
piperidine
groups
independently selected
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023578919A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024524215A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2022/067126 external-priority patent/WO2022268935A2/en
Publication of JP2024524215A publication Critical patent/JP2024524215A/ja
Publication of JP2024524215A5 publication Critical patent/JP2024524215A5/ja
Pending legal-status Critical Current

Links

JP2023578919A 2021-06-23 2022-06-23 Ｎｌｒｐ３阻害剤を調製するための方法 Pending JP2024524215A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN202141028180 2021-06-23
IN202141028180 2021-06-23
PCT/EP2022/067126 WO2022268935A2 (en) 2021-06-23 2022-06-23 Novel process

Publications (2)

Publication Number Publication Date
JP2024524215A JP2024524215A (ja) 2024-07-05
JP2024524215A5 true JP2024524215A5 (https=) 2025-06-27

Family

ID=82458485

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023578919A Pending JP2024524215A (ja) 2021-06-23 2022-06-23 Ｎｌｒｐ３阻害剤を調製するための方法

Country Status (12)

Country Link
US (1) US20240150291A1 (https=)
EP (1) EP4359385A2 (https=)
JP (1) JP2024524215A (https=)
KR (1) KR20240024842A (https=)
CN (1) CN118019727A (https=)
AR (1) AR126215A1 (https=)
AU (1) AU2022300325A1 (https=)
CA (1) CA3219597A1 (https=)
IL (1) IL308071A (https=)
MX (1) MX2023014547A (https=)
TW (1) TW202317514A (https=)
WO (1) WO2022268935A2 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR128498A1 (es) * 2022-02-15 2024-05-15 Hoffmann La Roche Procesos novedosos
WO2024133610A1 (en) * 2022-12-23 2024-06-27 F. Hoffmann-La Roche Ag Proccesses for the preparation of an nlrp3 inhibitor
IL325043A (en) 2023-08-16 2026-01-01 Hoffmann La Roche Process for the preparation of 1-ethyl-n-((1,2,3,5,6,7-hexahydro-s-indecen-4-yl)carbamoyl)piperidine-4-sulfonamide
WO2025153532A1 (en) 2024-01-16 2025-07-24 NodThera Limited Nlrp3 inhibitors and glp-1 agonists combination therapies

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69727837T2 (de) * 1997-05-02 2004-12-30 Dr. Reddy's Research Foundation, Hyderabad Neue antidiabetische verbindungen mit hypolipidimischen und antihypertensiven eigenschaften, verfahren zu ihrer herstellung und ihre enthaltenden arzneimittel
HUP0303204A3 (en) * 2000-11-16 2010-04-28 Sankyo Co 1-methylcarbapenem derivatives and pharmaceutical compositions containing them
WO2002100833A1 (en) * 2001-06-12 2002-12-19 Sumitomo Pharmaceuticals Company, Limited Rho KINASE INHIBITORS
US7220735B2 (en) * 2002-04-18 2007-05-22 Schering Corporation Benzimidazolone histamine H3 antagonists
TW200524865A (en) * 2003-10-08 2005-08-01 Nicholas Piramal India Ltd Fibrinogen receptor antagonists and their use
DOP2006000009A (es) * 2005-01-13 2006-08-15 Arena Pharm Inc Procedimiento para preparar eteres de pirazolo [3,4-d] pirimidina
JP5508027B2 (ja) * 2007-02-22 2014-05-28 メルク セローノ ソシエテ アノニム キノキサリン化合物及びその使用
JP5898962B2 (ja) * 2012-01-11 2016-04-06 東京応化工業株式会社 レジスト組成物及びレジストパターン形成方法
WO2017095758A1 (en) * 2015-12-01 2017-06-08 Merck Sharp & Dohme Corp. Homobispiperidinyl derivatives as liver x receptor beta agonists, compositions, and their use
US11465992B2 (en) * 2017-07-07 2022-10-11 Inflazome Limited Sulfonamide carboxamide compounds
GB201712282D0 (en) * 2017-07-31 2017-09-13 Nodthera Ltd Selective inhibitors of NLRP3 inflammasome
EP3668861A1 (en) * 2017-08-15 2020-06-24 Inflazome Limited Novel sulfonamide carboxamide compounds
EP3773576A4 (en) * 2018-03-26 2021-12-29 C4 Therapeutics, Inc. Cereblon binders for the degradation of ikaros
CR20200588A (es) * 2018-05-04 2021-06-24 Inflazome Ltd Compuestos novedosos
CA3113573A1 (en) * 2018-09-21 2020-03-26 Novartis Ag Isoxazole carboxamide compounds and uses thereof
GB201817038D0 (en) 2018-10-19 2018-12-05 Inflazome Ltd Novel processes
GB201819083D0 (en) * 2018-11-23 2019-01-09 Inflazome Ltd Novel compounds
WO2020157069A1 (en) * 2019-01-28 2020-08-06 NodThera Limited Amino heterocyclic compounds and uses thereof

Similar Documents

Publication Publication Date Title
JP2024524215A5 (https=)
JP2024099041A5 (https=)
JP2008101002A (ja) ウレイドのｎ−アルキル化のための方法及び試薬
JP2014523916A (ja) Ｎ−置換環状アルキレン尿素を合成する方法
WO1998046231A1 (en) Muscarinic agonist compounds
AU2010289802B2 (en) Synthesis of a neurostimulative piperazine
KR20160095161A (ko) 포스파티딜이노시톨 3-키나제 억제제의 가공 방법
Hazarika et al. Facile, catalyst-free cascade synthesis of sulfonyl guanidines via carbodiimide coupling with amines
JP2014523915A (ja) 環状アルキレン尿素を合成する方法
KR102708701B1 (ko) 벤즈이미다졸 유도체의 제조방법
JP2002534409A5 (https=)
JP2004517897A (ja) テモゾロミドおよびアナログの合成
CA2264298A1 (en) Catalytic selective sulfonylation process
CN1054849C (zh) 季铵化氨基乙腈的制备
CN109096174B (zh) 一种n-烃基-2,5-未取代的[60]富勒烯吡咯烷衍生物的合成方法
CN113087689A (zh) 5-氨基-γ-内酯衍生物的简便合成方法
RU2024101439A (ru) Новый способ
WO2001021592A1 (en) Processes for the preparation of 4(5)-amino-5(4)-carboxamidoimidazoles and intermediates thereof
US20040024217A1 (en) Synthesis of piperidine and piperazine compounds as CCR5 antagonists
US6730796B2 (en) Process for preparation of N-substituted 2-sulfanylimidazoles
JP2025506671A5 (https=)
JPWO2018043215A1 (ja) チオグリコールウリル類及びその製造方法
US3905992A (en) N,N{40 -alkylenebis(2-amino-1-(2-imidazolin-2-yl)-2-imidazolines)
US3278542A (en)
CN112409116B (zh) 一种胺基脂肪族硒氰酸酯类化合物的制备方法